BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27487997)

  • 21. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
    Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J
    J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stockpiling oral cholera vaccine.
    Martin S; Costa A; Perea W
    Bull World Health Organ; 2012 Oct; 90(10):714. PubMed ID: 23109735
    [No Abstract]   [Full Text] [Related]  

  • 23. Emergence of Vibrio cholerae O139.
    Sack RB; Albert MJ; Siddique AK
    Curr Clin Top Infect Dis; 1996; 16():172-93. PubMed ID: 8714254
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunisation against cholera with a Ty21a-cholera hybrid.
    La Brooy JT; Forrest B; Bartholomeusz C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):143-7. PubMed ID: 3426872
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cholera vaccine].
    Ehara M
    Nihon Rinsho; 2005 May; 63 Suppl 5():625-30. PubMed ID: 15954420
    [No Abstract]   [Full Text] [Related]  

  • 26. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
    Viret JF; Dietrich G; Favre D
    Vaccine; 2004 Jun; 22(19):2457-69. PubMed ID: 15193410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CpG DNA, liposome and refined antigen oral cholera vaccine.
    Leelawongtawon R; Somroop S; Chaisri U; Tongtawe P; Chongsa-nguan M; Kalambaheti T; Tapchaisri P; Pichyangkul S; Sakolvaree Y; Kurazono H; Hayashi H; Chaicumpa W
    Asian Pac J Allergy Immunol; 2003 Dec; 21(4):231-9. PubMed ID: 15198341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can oral cholera vaccination play a role in controlling a cholera outbreak?
    Calain P; Chaine JP; Johnson E; Hawley ML; O'Leary MJ; Oshitani H; Chaignat CL
    Vaccine; 2004 Jun; 22(19):2444-51. PubMed ID: 15193408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cholera in Europe today].
    Dal Fabbro G
    Minerva Med; 1972; 63(7):409-12. PubMed ID: 4664871
    [No Abstract]   [Full Text] [Related]  

  • 30. Cholera in the Gilbert Island. I. Epidemiological features.
    Kuberski T; Flood T; Tera T
    Am J Trop Med Hyg; 1979 Jul; 28(4):677-84. PubMed ID: 464187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis and prevention of cholera.
    Holmgren J
    Scand J Infect Dis Suppl; 1982; 36():58-64. PubMed ID: 6963754
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunogenicity of liposome-associated oral cholera vaccine prepared from combined Vibrio cholerae antigens.
    Chaicumpa W; Parairo JR; New RC; Pongponratn E; Ruangkunaporn Y; Tapchaisri P; Chongsa-nguan M
    Asian Pac J Allergy Immunol; 1990 Dec; 8(2):87-94. PubMed ID: 2091663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral cholera vaccine development and use in Vietnam.
    Anh DD; Lopez AL; Tran HT; Cuong NV; Thiem VD; Ali M; Deen JL; von Seidlein L; Sack DA
    PLoS Med; 2014 Sep; 11(9):e1001712. PubMed ID: 25180511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India.
    Kar SK; Pach A; Sah B; Kerketta AS; Patnaik B; Mogasale V; Kim YH; Rath SB; Shin S; Khuntia HK; Bhattachan A; Puri MK; Wierzba TF; Kaljee LM
    Hum Vaccin Immunother; 2014; 10(10):2834-42. PubMed ID: 25483631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From the National Institute of Allergy and Infectious Diseases. Summary of the 21st United States-Japan Joint Cholera Conference.
    Edelman R; Sack RB
    J Infect Dis; 1986 Aug; 154(2):377-80. PubMed ID: 3722875
    [No Abstract]   [Full Text] [Related]  

  • 36. Assay of cholera vaccine potency.
    Mumford JA; Ford AW; Richer PR
    J Biol Stand; 1977; 5(4):351-67. PubMed ID: 925045
    [No Abstract]   [Full Text] [Related]  

  • 37. Cholera.
    Hirschhorn N; Greenough WB
    Sci Am; 1971 Aug; 225(2):15-21. PubMed ID: 5089453
    [No Abstract]   [Full Text] [Related]  

  • 38. Not one but four possible oral vaccines for cholera under study.
    Henahan J
    JAMA; 1982 Oct; 248(16):1937-8. PubMed ID: 7120612
    [No Abstract]   [Full Text] [Related]  

  • 39. [Apudocytes in experimental cholera vaccination].
    Bugorkova SA; Isupov IV; Nazarova LS; Eliseev IuIu
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (4):27-31. PubMed ID: 11569256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholera vaccines.
    Tacket CO; Clemens J; Kaper JB
    Biotechnology; 1992; 20():53-68. PubMed ID: 1600389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.